Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
$9.70
$8.70
$30.96
$133.71M0.62185,176 shs534,900 shs
Cortexyme, Inc. stock logo
CRTX
Cortexyme
$1.13
+6.1%
$1.29
$1.78
$40.66
$33.92M1.4620,672 shs97,379 shs
Veradigm Inc. stock logo
MDRX
Veradigm
$4.40
+6.0%
$4.61
$3.80
$11.80
$476.37M0.63406,213 shs312 shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$30.96
-0.8%
$34.50
$25.12
$55.75
$1.45B0.78536,349 shs454,205 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
0.00%0.00%0.00%0.00%0.00%
Cortexyme, Inc. stock logo
CRTX
Cortexyme
+0.95%+6.00%-24.29%-33.54%-4.50%
Veradigm Inc. stock logo
MDRX
Veradigm
+6.02%+6.02%+5.01%-43.59%-45.21%
Omnicell, Inc. stock logo
OMCL
Omnicell
+1.69%+3.07%-9.46%-28.47%+13.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Cortexyme, Inc. stock logo
CRTX
Cortexyme
N/AN/AN/AN/AN/AN/AN/AN/A
Veradigm Inc. stock logo
MDRX
Veradigm
2.5562 of 5 stars
3.30.00.04.11.40.00.0
Omnicell, Inc. stock logo
OMCL
Omnicell
2.3719 of 5 stars
3.22.00.00.02.91.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
0.00
N/AN/AN/A
Cortexyme, Inc. stock logo
CRTX
Cortexyme
0.00
N/AN/AN/A
Veradigm Inc. stock logo
MDRX
Veradigm
2.50
Moderate Buy$14.00218.18% Upside
Omnicell, Inc. stock logo
OMCL
Omnicell
2.33
Hold$50.6763.65% Upside

Current Analyst Ratings Breakdown

Latest CPSI, MDRX, CRTX, and OMCL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2025
Omnicell, Inc. stock logo
OMCL
Omnicell
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$40.00 ➝ $38.00
3/20/2025
Omnicell, Inc. stock logo
OMCL
Omnicell
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$44.00 ➝ $36.00
2/4/2025
Omnicell, Inc. stock logo
OMCL
Omnicell
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$62.00 ➝ $62.00
1/31/2025
Veradigm Inc. stock logo
MDRX
Veradigm
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$7.00 ➝ $13.00
(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
$339.43M0.00N/A1.53$12.83 per share0.00
Cortexyme, Inc. stock logo
CRTX
Cortexyme
N/AN/AN/AN/A$3.97 per shareN/A
Veradigm Inc. stock logo
MDRX
Veradigm
$1.53B0.31N/AN/AN/A
Omnicell, Inc. stock logo
OMCL
Omnicell
$1.11B1.30$2.39 per share12.95$26.84 per share1.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
-$45.79M-$3.15N/A0.00N/A-13.49%10.33%5.23%N/A
Cortexyme, Inc. stock logo
CRTX
Cortexyme
-$89.94M-$2.97N/AN/AN/AN/A-70.96%-63.53%N/A
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/A0.00N/AN/AN/AN/AN/A
Omnicell, Inc. stock logo
OMCL
Omnicell
$12.53M$0.27114.6724.977.531.13%3.82%2.07%5/6/2025 (Estimated)

Latest CPSI, MDRX, CRTX, and OMCL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Omnicell, Inc. stock logo
OMCL
Omnicell
$0.16N/AN/AN/A$260.18 millionN/A
2/6/2025Q4 2024
Omnicell, Inc. stock logo
OMCL
Omnicell
$0.57$0.45-$0.12$0.34$297.88 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
N/AN/AN/AN/AN/A
Cortexyme, Inc. stock logo
CRTX
Cortexyme
N/AN/AN/AN/AN/A
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/AN/AN/AN/A
Omnicell, Inc. stock logo
OMCL
Omnicell
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
1.05
2.32
2.31
Cortexyme, Inc. stock logo
CRTX
Cortexyme
N/A
9.92
9.92
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/AN/A
Omnicell, Inc. stock logo
OMCL
Omnicell
0.13
1.37
1.22

Institutional Ownership

CompanyInstitutional Ownership
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
88.64%
Cortexyme, Inc. stock logo
CRTX
Cortexyme
63.18%
Veradigm Inc. stock logo
MDRX
Veradigm
N/A
Omnicell, Inc. stock logo
OMCL
Omnicell
97.70%

Insider Ownership

CompanyInsider Ownership
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
2.80%
Cortexyme, Inc. stock logo
CRTX
Cortexyme
27.90%
Veradigm Inc. stock logo
MDRX
Veradigm
2.29%
Omnicell, Inc. stock logo
OMCL
Omnicell
2.52%
CompanyEmployeesShares OutstandingFree FloatOptionable
Computer Programs and Systems, Inc. stock logo
CPSI
Computer Programs and Systems
2,50014.55 million14.14 millionOptionable
Cortexyme, Inc. stock logo
CRTX
Cortexyme
5530.15 million21.74 millionNot Optionable
Veradigm Inc. stock logo
MDRX
Veradigm
8,000108.27 million105.18 millionNo Data
Omnicell, Inc. stock logo
OMCL
Omnicell
3,80046.84 million45.09 millionOptionable

Recent News About These Companies

Omnicell (NASDAQ:OMCL) Upgraded by StockNews.com to Buy Rating
First Week of OMCL June 20th Options Trading
Omnicell price target lowered to $38 from $40 at Wells Fargo

New MarketBeat Followers Over Time

Media Sentiment Over Time

Computer Programs and Systems stock logo

Computer Programs and Systems NASDAQ:CPSI

Computer Programs and Systems, Inc. provides healthcare information technology solutions and services in the United States and the Caribbean nation of St. Maarten. Its software systems include patient management software that enables a hospital to identify a patient at various points in the healthcare delivery system, as well as to collect and maintain patient information throughout the process of patient care; and financial accounting software, which offers business office applications to track and coordinate information needed for managerial decision-making. The company also provides clinical software that automates record keeping and reporting for various clinical functions, including laboratory, radiology, physical therapy, respiratory care, and pharmacy; patient care applications; and enterprise applications that support its products for use in various areas of the hospital. In addition, it offers Centriq, an intuitive user interface to centralize data from various care areas that provide the end user with a tool to view past and present patient information. Further, the company provides post-acute care software systems; software application support, hardware maintenance, and education and related services; post-acute care support and maintenance services; revenue cycle management products and services, consulting and business management services, and managed information technology services; patient engagement, and encoder solutions. It serves community hospitals and physician clinics, skilled nursing, and assisted living facilities. Computer Programs and Systems, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.

Cortexyme stock logo

Cortexyme NASDAQ:CRTX

$1.12 +0.07 (+6.13%)
As of 04/24/2025

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Veradigm stock logo

Veradigm NASDAQ:MDRX

$4.40 +0.25 (+6.02%)
As of 09:33 AM Eastern

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Omnicell stock logo

Omnicell NASDAQ:OMCL

$30.96 -0.25 (-0.80%)
Closing price 04:00 PM Eastern
Extended Trading
$32.44 +1.48 (+4.78%)
As of 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.